CROCI, STEFANIA
 Distribuzione geografica
Continente #
NA - Nord America 361
EU - Europa 341
AS - Asia 76
AF - Africa 1
Totale 779
Nazione #
US - Stati Uniti d'America 360
GB - Regno Unito 165
IE - Irlanda 62
CN - Cina 33
UA - Ucraina 25
SE - Svezia 20
RU - Federazione Russa 19
VN - Vietnam 18
IT - Italia 14
FR - Francia 12
SG - Singapore 11
FI - Finlandia 8
TR - Turchia 8
DE - Germania 4
ES - Italia 4
IN - India 3
AT - Austria 2
BE - Belgio 2
AL - Albania 1
BD - Bangladesh 1
CA - Canada 1
CI - Costa d'Avorio 1
IR - Iran 1
LT - Lituania 1
NO - Norvegia 1
PK - Pakistan 1
PL - Polonia 1
Totale 779
Città #
Southend 157
Dublin 59
Fairfield 56
Chandler 39
Ashburn 34
Seattle 24
Menlo Park 23
Wilmington 20
Woodbridge 20
Jacksonville 19
Dong Ket 18
Cambridge 17
Ann Arbor 16
Beijing 10
Houston 10
Dearborn 9
Helsinki 8
Izmir 8
New York 8
Princeton 8
Siena 8
Singapore 8
Fremont 5
Munich 4
Málaga 4
Shanghai 4
Shenyang 4
Boardman 3
Hebei 3
Phoenix 3
San Diego 3
Brussels 2
Florence 2
Jinan 2
Moscow 2
Nanchang 2
San Mateo 2
Santa Clara 2
Sezze 2
Tianjin 2
Vienna 2
Abidjan 1
Bangalore 1
Dhaka 1
Edinburgh 1
Fuzhou 1
Guangzhou 1
Hangzhou 1
Hounslow 1
Islamabad 1
Kilburn 1
Kunming 1
Kyiv 1
London 1
Oslo 1
Philadelphia 1
Saint Louis 1
San Francisco 1
Sandston 1
Taizhou 1
Tirana 1
Warsaw 1
Washington 1
Winnipeg 1
Zanjan 1
Totale 656
Nome #
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients 249
3D bone texture analysis as a potential predictor of radiationinduced insufficiency fractures 211
Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab 182
Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev). 155
Totale 797
Categoria #
all - tutte 2.158
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.158


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020121 0 0 0 0 14 19 24 20 17 16 4 7
2020/2021128 5 12 0 19 7 16 2 18 10 9 4 26
2021/202277 5 13 5 1 7 1 6 6 6 6 7 14
2022/2023104 4 13 15 17 12 15 1 8 7 6 4 2
2023/202498 1 1 6 4 1 31 47 0 2 0 0 5
2024/202541 6 7 19 7 2 0 0 0 0 0 0 0
Totale 797